Cryptogenic cirrhosis and sitosterolemia: A treatable disease if identified but fatal if missed

Annals of Hepatology

Volumn 16, Issue 6, 2017, Pages 970-978

  Bazerbachi, Fateh ^a   Conboy, Erin E ^a   Mounajjed, Taofic ^a   Watt, Kymberly D ^a   Babovic Vuksanovic, Dusica ^a   Patel, Shailendra B ^b   Kamath, Patrick S ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

ABCG5; ABCG8; Ascites; Cryptogenic cirrhosis; Idiopathic cirrhosis; Macrothrombocytopenia; Phytosterolemia; Plant sterols; Premature coronary artery disease; Sitosterolemia

Indexed keywords

LACTATE DEHYDROGENASE; ABC TRANSPORTER G5; ABCG5 PROTEIN, HUMAN; EZETIMIBE; HYPOCHOLESTEROLEMIC AGENT; LIPOPROTEIN; PHYTOSTEROL;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; CAUSE OF DEATH; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ANGIOGRAPHY; DISEASE ASSOCIATION; DYSPNEA; EYE JAUNDICE; FATIGUE; FLAPPING TREMOR; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; JAUNDICE; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MUSCULOSKELETAL SYSTEM EXAMINATION; NEUROLOGIC EXAMINATION; PAKISTANI; SITOSTEROLEMIA; TENDON DISEASE; TENDON XANTHOMA; THORAX PAIN; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UNSTABLE ANGINA PECTORIS; VASCULITIS; XANTHOMA; YOUNG ADULT; BIOPSY; COMPLICATION; CORONARY ARTERY DISEASE; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DNA MUTATIONAL ANALYSIS; ELECTRON MICROSCOPY; ENTEROPATHY; FATALITY; GENETIC PREDISPOSITION; GENETICS; HEMOLYTIC ANEMIA; HEREDITY; HOMOZYGOTE; HYPERCHOLESTEROLEMIA; LOW FAT DIET; MUTATION; PEDIGREE; PHENOTYPE; RISK FACTOR; TREATMENT OUTCOME; XANTHOMATOSIS;

ANEMIA, HEMOLYTIC; ANTICHOLESTEREMIC AGENTS; ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY G, MEMBER 5; BIOPSY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIET, FAT-RESTRICTED; DNA MUTATIONAL ANALYSIS; EZETIMIBE; FATAL OUTCOME; GENETIC PREDISPOSITION TO DISEASE; HEREDITY; HOMOZYGOTE; HUMANS; HYPERCHOLESTEROLEMIA; INTESTINAL DISEASES; LIPID METABOLISM, INBORN ERRORS; LIPOPROTEINS; LIVER CIRRHOSIS; MALE; MICROSCOPY, ELECTRON; MUTATION; PEDIGREE; PHENOTYPE; PHYTOSTEROLS; RISK FACTORS; TREATMENT OUTCOME; XANTHOMATOSIS; YOUNG ADULT;

EID: 85031930427     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.5604/01.3001.0010.5290     Document Type: Article

References (26)

1. Bhattacharyya AK, Connor WE. Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J Clin Invest 1974: 53: 1033-43. doi: 10.1172/JCI107640.
2. Patel SB, Salen G. Sitosterolemia: xenophobia for the body. In: Vissers MN, Kastelein JJP, Stroes ES (eds.). Evidence-based Management of Lipid Disorders. Harley: tfm Publishing Ltd; 2010. p. 217-30.
3. Salen G, Ahrens EHJr, Grundy SM. Metabolism of beta-sito-sterol in man. J Clin Invest 1970: 49: 952-67. doi: 10.1172/JCI106315.
4. Patel SB, Salen G, Hidaka H, Kwiterovich PO, Stalenhoef AFH, Miettinen TA, Grundy SM, et al. Mapping a gene involved in regulating dietary cholesterol absorption. The sitosterolemia locus is found at chromosome 2p21. J Clin Invest 1998: 102: 1041-4. doi: 10.1172/jci3963.
5. Lu K, Lee MH, Hazard S, Brooks-Wilson A, Hidaka H, Kojima H, Ose L, et al. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet 2001: 69: 278-90.
6. Lee MH, Lu K, Hazard S, Yu H, Shulenin S, Hidaka H, Kojima H, et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 2001: 27: 79-83. doi: 10.1038/83799.
7. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, Kwiterovich P, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000: 290: 1771-5.
8. Miettinen TA, Klett EL, Gylling H, Isoniemi H, Patel SB. Liver transplantation in a patient with sitosterolemia and cirrhosis. Gastroenterology 2006: 130: 542-7.
9. Fazio S, Linton MF. Evidence-based Management of Lipid Disorders. 2011.
10. Kurvinen A, Nissinen MJ, Andersson S, Korhonen P, Ruuska T, Taimisto M, Kalliomaki M, et al. Parenteral plant sterols and intestinal failure-associated liver disease in neonates. J Pediatr Gastroenterol Nutrit 2012: 54: 803-11. doi: 10.1097/MPG.0b013e3182474118.
11. Mushtaq T, Wales JK, Wright NP. Adrenal insufficiency in phytosterolaemia. Eur J Endocrinol 2007: 157(Suppl. 1): S61-5. doi: 10.1530/EJE-07-0222.
12. Hatanaka I, Yasuda H, Hidaka H, Harada N, Kobayashi M, Okabe H, Matsumoto K, et al. Spinal cord compression with paraplegia in xanthomatosis due to normocholesterolemic sitosterolemia. Ann Neurol 1990: 28: 390-3. doi: 10.1002/ana.410280316.
13. Salen G, Shefer S, Berginer V. Familial diseases with storage of sterols other than cholesterol: Cerebrotendinous xanthomatosis and sitosterolemia with xanthomatosis. In Stanbury JB, Wyngaarden JB, Frederickson DS, et al. (Eds): The Metabolic Basis of Inherited Disease. ed 5. New York: McGraw-Hill Book Co; 1982, pp. 713-24.
14. Hidaka H, Nakamura T, Aoki T, Kojima H, Nakajima Y, Kosugi K, Hatanaka I, et al. Increased plasma plant sterol levels in heterozygotes with sitosterolemia and xanthomatosis. J Lip Res 1990: 31: 881-8.
15. Gylling H, Vuoristo M, Farkkila M, Miettinen TA. The metabolism of cholestanol in primary biliary cirrhosis. J Hepatol 1996: 24: 444-51.
16. Kurvinen A, Nissinen MJ, Andersson S, Korhonen P, Ruuska T, Taimisto M, Kalliomaki M, et al. Parenteral plant sterols and intestinal failure-associated liver disease in neonates. J Pediatr Gastroenterol Nutr 2012: 54: 803-11. doi: http://dx.doi.org/10.1097/MPG.0b013e3182474118.
17. Hukkinen M, Mutanen A, Nissinen M, Merras-Salmio L, Gylling H, Pakarinen MP. Parenteral Plant Sterols Accumulate in the Liver Reflecting Their Increased Serum Levels and Portal Inflammation in Children With Intestinal Failure. Jpen J Parent-er Enteral Nutr 2016:9:9. doi: http://dx.doi.org/10.1177/0148607116637855.
18. Li Y, Salfelder A, Schwab KO, Grünert SC, Velten T, Lütjo-hann D, Villavicencio-Lorini P, et al. Against all odds: blended phenotypes of three single-gene defects. Eur J Hum Genet 2016; 24: 1274-9.
19. Mannucci L, Guardamagna O, Bertucci P, Pisciotta L, Libera-toscioli L, Bertolini S, Irace C, et al. Beta-sitosterolaemia: a new nonsense mutation in the ABCG5 gene. Eur J Clin Invest 2007: 37: 997-1000.
20. Lek M, Karczewski K, Minikel E, Samocha K, Banks E, Fennell T, O’Donnell-Luria A, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016: 536: 285–91. doi:10.1038/nature19
21. Garg A. Dyslipidemias: Pathophysiology, Evaluation and Management. Springer; 2015.
22. Wang Z, Cao L, Su Y, Wang G, Wang R, Yu Z, Bai X, et al. Specific macrothrombocytopenia/hemolytic anemia associated with sitosterolemia. Am J Hematol 2014: 89: 320-4. doi: http://dx.doi.org/10.1002/ajh.23619.
23. Nussbaum RL, McInnes RR, Willard HF. Thompson & Thompson genetics in medicine. Elsevier Health Sciences; 2015.
24. BIOBASE biological databases. Available at: URL. Access: 2016/10/09.
25. Solca C, Tint GS, Patel SB. Dietary xenosterols lead to infertility and loss of abdominal adipose tissue in sterolin-defi-cient mice. J Lipid Res 2013: 54: 397-409. doi: 10.1194/jlr.M031476.
26. Musliner T, Cselovszky D, Sirah W, McCrary Sisk C, Sapre A, Salen G, Lutjohann D, et al. Efficacy and safety of ezetimibe 40 mg vs. ezetimibe 10 mg in the treatment of patients with homozygous sitosterolaemia. Int J Clin Pract 2008: 62: 995-1000. doi: http://dx.doi.org/10.1111/j.1742-1241.2008.01786.x.